| Disease | Target Count | P-value |
|---|---|---|
| oligodendroglioma | 2850 | 4.5e-11 |
| ulcerative colitis | 1819 | 1.1e-06 |
| medulloblastoma, large-cell | 6241 | 3.2e-05 |
| lung cancer | 4740 | 8.6e-05 |
| lung adenocarcinoma | 2716 | 1.7e-04 |
| atypical teratoid / rhabdoid tumor | 5112 | 5.9e-04 |
| psoriasis | 6694 | 8.0e-04 |
| osteosarcoma | 7950 | 1.8e-03 |
| Atopic dermatitis | 952 | 2.2e-03 |
| ovarian cancer | 8520 | 5.0e-03 |
| primitive neuroectodermal tumor | 3035 | 5.2e-03 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 6.4e-03 |
| ependymoma | 4679 | 6.6e-03 |
| Parkinson's disease | 392 | 7.9e-03 |
| astrocytic glioma | 2597 | 1.6e-02 |
| glioblastoma | 5792 | 1.8e-02 |
| Pick disease | 1894 | 3.1e-02 |
| group 3 medulloblastoma | 4104 | 3.4e-02 |
| adult high grade glioma | 3801 | 4.2e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Narcolepsy | 72 | 3.605 | 1.8 |
| Disease | log2 FC | p |
|---|---|---|
| adult high grade glioma | -1.200 | 4.2e-02 |
| astrocytic glioma | -1.200 | 1.6e-02 |
| Atopic dermatitis | -1.100 | 2.2e-03 |
| atypical teratoid / rhabdoid tumor | -2.500 | 5.9e-04 |
| ependymoma | -1.500 | 6.6e-03 |
| glioblastoma | -1.300 | 1.8e-02 |
| group 3 medulloblastoma | -1.700 | 3.4e-02 |
| intraductal papillary-mucinous adenoma (... | 1.700 | 6.4e-03 |
| lung adenocarcinoma | 1.149 | 1.7e-04 |
| lung cancer | 3.700 | 8.6e-05 |
| medulloblastoma, large-cell | -2.600 | 3.2e-05 |
| oligodendroglioma | -1.200 | 4.5e-11 |
| osteosarcoma | 1.431 | 1.8e-03 |
| ovarian cancer | 1.600 | 5.0e-03 |
| Parkinson's disease | -2.100 | 7.9e-03 |
| Pick disease | -1.100 | 3.1e-02 |
| primitive neuroectodermal tumor | -1.500 | 5.2e-03 |
| psoriasis | -1.300 | 8.0e-04 |
| ulcerative colitis | -1.300 | 1.1e-06 |
MTKDKNSPGLKKKSQSVDINAPGFNPLAGAGKQTPQASKPPAPKTPIIEEEQNNAANTQKHPSRRSELKR 1 - 70 FYTIDTGQKKTLDKKDGRRMSFQKPKGTIEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVL 71 - 140 YVPDPEYVSSVESSPSLSPVSPLSPTSSEAEFDKTTNPDVHPTEATPSSTFTGIRPARVVSSTSEEEEAF 141 - 210 TEKFLKINCKYITSGKGTVSGVLLVTPNNIMFDPHKNDPLVQENGCEEYGIMCPMEEVMSAAMYKEILDS 211 - 280 KIKESLPIDIDQLSGRDFCHSKKMTGSNTEEIDSRIRDAGNDSASTAPRSTEESLSEDVFTESELSPIRE 281 - 350 ELVSSDELRQDKSSGASSESVQTVNQAEVESLTVKSESTGTPGHLRSDTEHSTNEVGTLCHKTDLNNLEM 351 - 420 AIKEDQIADNFQGISGPKEDSTSIKGNSDQDSFLHENSLHQEESQKENMPCGETAEFKQKQSVNKGKQGK 421 - 490 EQNQDSQTEAEELRKLWKTHTMQQTKQQRENIQQVSQKEAKHKITSADGHIESSALLKEKQRHRLHKFLC 491 - 560 LRVGKPMRKTFVSQASATMQQYAQRDKKHEYWFAVPQERTDHLYAFFIQWSPEIYAEDTGEYTREPGFIV 561 - 630 VKKIEESETIEDSSNQAAAREWEVVSVAEYHRRIDALNTEELRTLCRRLQITTREDINSKQVATVKADLE 631 - 700 SESFRPNLSDPSELLLPDQIEKLTKHLPPRTIGYPWTLVYGTGKHGTSLKTLYRTMTGLDTPVLMVIKDS 701 - 770 DGQVFGALASEPLKVSDGFYGTGETFVFTFCPEFEVFKWTGDNMFFIKGDMDSLAFGGGGGEFALWLDGD 771 - 840 LYHGRSHSCKTFGNRTLSKKEDFFIQDIEIWAFE 841 - 874 //
